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UNCERTAINTIES
What is the best way to manage neurogenic bowel
dysfunction?
Doreen McClurg professor of physiotherapy and the pelvic floor 1, Christine Norton professor of
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1Nursing Midwifery and Allied Health Professions Research Unit, Glasgow Caledonian University, Glasgow G4 0BA, UK; 2King’s College London
School of Medical Education, Florence Nightingale School of Nursing and Midwifery, London, UK
A single episode of faecal incontinence can precipitate a fear
of repetition and may lead to reduced social activity and
isolation. Bowel dysfunction, faecal incontinence, and
constipation have a prevalence of around 70% in people with
central neurological disease such as Parkinson’s disease, stroke,
multiple sclerosis, or spinal cord injury. Tools such as the Bristol
Stool Chart have been developed to aid conversation about
bowel dysfunction (fig 1). Constipation may lead to difficult
evacuation, abdominal pain and bloating, haemorrhoids, anal
fissures, rectal bleeding, prolapse, and autonomic dysreflexia.
Hospital admission for impaction occurs more than twice as
frequently as in healthy people.Management to ameliorate either
incontinence or constipation risks precipitating the other. The
condition is time consuming and arduous and causes anxiety to
the patient and care givers.
What is the evidence of the uncertainty?
Various approaches have been tried for faecal incontinence and
constipation in these patients, but limited research is available
to allow recommendations for care to be made. An updated
Cochrane review published in 2014 identified 20 randomised
controlled trials (902 participants) comparing different
management strategies (table 1⇓). Five studies that reported on
the use of cisapride and tegaserod were excluded from this
update owing to adverse cardiovascular effects. Limited
evidence from individual trials suggests improvement in bowel
function with a bulk forming laxative (psyllium), an isosmotic
macrogol laxative, abdominal massage, transanal irrigation, and
sacral nerve stimulation. Some suppositories were effective in
aiding bowel movements, particularly with morning use. One
study found digital evacuation of stools to be more effective
than oral or rectal drugs. Overall, the review concluded that the
evidence was of very poor quality as most studies are small and
not reliably reported.
Using the same search criteria, we updated the Cochrane
searches and identified eight additional randomised controlled
trials (367 participants) on the role of physical interventions
such as daily standing and abdominal massage, acupuncture,
electrical stimulation, and drugs. However, these additional
studies are small and at high risk of bias (table 1⇓).
Is ongoing research likely to provide
relevant evidence?
We searched clinicaltrials.gov for ongoing studies and found
one trial, which is our own Health Technology Assessment
funded trial comparing abdominal massage plus advice with
advice alone in people with multiple sclerosis (200 participants),
which will report in 2017. A qualitative study is ongoing in
patients with multiple sclerosis to evaluate the effect of bowel
dysfunction on quality of life and their experience in accessing
services.
What should we do in the light of the
uncertainty?
Cisapride and tegaserod should not be prescribed. Guidance on
faecal incontinence from the National Institute for Health and
Care Excellence (NICE) suggests that clinicians should
proactively ask about symptoms as patients may not volunteer
the information. Explain to patients that, although evidence is
poor, clinicians have some experience with a variety of options
and it may be a case of trying the simpler ones such as diet
modification to start with.
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What you need to know
• Constipation and faecal incontinence are common in patients with central neurological disease and may prove difficult to manage
• Limited evidence and clinical expertise suggest that diet modification, oral laxatives, rectal stimulants, digital stimulation, manual
evacuation of faeces, and abdominal massage are options that may be tried
• Quality data to support these approaches are lacking, and trials are needed in mixed groups of patients to explore the efficacy of
common approaches alone and in combination
On the basis of guidance from theMultidisciplinary Association
of Spinal Cord Injured Professionals, we recommend a stepwise
approach to establish a regular pattern that is comfortable for
the patient, using any number of the possible interventions alone
or in combination:
• Establish an appropriate diet—for example, avoid
insufficient or excessive fibre, attempt three meals a day,
and aim for liquid intake of at least 1.5 L per day.
• Aim to establish a bowel habit by a routine of attempting
defecation when peristalsis is likely to be maximal (after
meals).
• Make sure the patient can access the toilet or is supported
in doing so as needed.
• Review drugs that could exacerbate either constipation (for
example, analgesics) or faecal incontinence (for example,
laxatives or antacids).
• Consider oral laxatives or rectal suppositories alone or in
combination.
• A continence nurse specialist could teach abdominal
massage, manual evacuation, digital stimulation, or
transanal irrigation to the patient or carer to aid self
management.
Consider referral to a specialist service if symptoms remain
unsolved. A combination of anorectal physiology tests, gut
transit studies (fig 2), and endoanal ultrasonography will assist
in determining whether further management, such as surgery,
is appropriate.
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Recommendations for future research
As most commonly used approaches are poorly researched, a need exists for adequately powered randomised controlled trials as below:
• Population—People with various neurological conditions
• Interventions—Individual and combined approaches for constipation and faecal incontinence
• Outcomes—Standardised outcomemeasures such as the Neurogenic Bowel Dysfunction Score, which records frequency of defecation,
time spent trying to defecate, frequency of faecal or flatal incontinence, interventions such as drugs or digital stimulation, and perianal
skin problems; acceptability of interventions to patients
Additionally, research on innovative faecal containment devices is needed
How patients were involved in creation of this article
We discussed a draft of this paper with five patients with neurogenic bowel dysfunction. They stressed the need for information on self
management strategies such as diet and use of laxatives and on drugs that could make them constipated, as often they might receive
misleading information (such as all fibre is good).
Establishing a routine, if possible, was important for both patients and their carers. They wanted to know how to decide which adjunctive
treatment may be tried when symptoms did not respond. In patients with faecal incontinence, containment of faecal matter was a major
challenge.
With their comments, we reduced the use of medical terminology in the article and highlighted the impact of bowel dysfunction on quality of
life of these patients
Education into practice
• Do you routinely ask patients with neurological conditions whether they have bowel symptoms?
Table
Table 1| Overview of evidence
Additional





–Harari 2004MediumSome benefit1; 146StrokeEducation
–Coggrave 2010MediumNo change1; 68Spinal cord injuryStepwise advice
–Mun 2011HighSome benefit1; 34StrokeCarbonated water
–Dahl 2005HighNo change1; 15Wheel chairInulin fortified beverage
Physical interventions
Kwok 2015–HighNo effect1; 20Spinal cord injuryDaily standing
–Emly 1998MediumLimited benefit4; 125MixedAbdominal massage
–Jeon 2005HighSome benefit1; 31Stroke
–McClurg 2011LowSome benefit1; 30Multiple sclerosis
McClurg 2013–LowSome benefit1 ;30Parkinson’s disease
Drugs
–Asraf 1997HighNo benefit1; 7Parkinson’s diseasePsyllium
–Zangaglia 2007HighNo benefit1; 57Parkinson’s diseaseIsosmotic macrogol
–Medaer 1999HighSome benefit1; 11Multiple sclerosisPrucalopride
–Krogh 2002MediumNot significant1; 23Spinal cord injury
–Korsten2005HighSome benefit1; 18Spinal cord injuryIntravenous
neostigmine-glycopyrrolate
–Rosman 2008MediumSome benefit1; 7
Ondo 2012–HighMarked benefit1; 54Parkinson’s diseaseLubiprostone
Grijalva 2007–HighMarked benefit1; 27Spinal cord injury4-aminopyridine
Rectal stimulants
–Cornell 1973HighMarked benefit2; 75Spinal cord injuryPolyethylene glycol
based bisacodyl suppository
–House 1997Some benefit
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studies identifiedCochrane review2014*Risk of biasOutcome
No of studies;
participantsPopulationApproach
–Venn 1992HighMorning better1; 46StrokeTiming of suppository use
Chinese remedies
Ren 2013–MediumSome benefit2; 75StrokeAcupuncture
Xiao 2011–MediumSome benefit1; 160
–Huang 2002HighDifficult to interpret1; 200StrokeChinese medication
Electrical stimulation
Worsøe 2012–HighInhibitory effect on rectum1; 7Spinal cord injuryDorsal genital nerve
–Korstein 2004HighSignificant benefit1; 8Spinal cord injuryAbdominal muscles
–Wang 2008High–1; 80StrokeElectro acupuncture
Khan 2014–HighUnclear1; 12Multiple sclerosisSacral nerve stimulation
1; 5Spinal cord injury
Other
–Christensen 2006LowBenefit1; 87Spinal cord injuryTransanal irrigation
*See Cochrane review for full references.
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Figures
Fig 1 Bristol Stool Chart
Fig 2 Constipation markers. Coloured x ray of silicone markers (dots, highlighted yellow) that are being used to diagnose
the severity of a patient's constipation. These markers are still in the digestive system six days after being swallowed.
Normally, food passes through the digestive system in a day or two. The image also shows the bones (green) of the pelvis
(across bottom) and the spine (down centre), as well as the lowest ribs (top)
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